# InMed Pharmaceuticals Inc.: filings

INM · Nasdaq · CIK 1728328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/inm.md) · [Financials](/companies/inm/financials.md) · [Filings](/companies/inm/filings.md) · [Insiders](/companies/inm/insiders.md)

## Reports and events: 220 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 166, 4 118, CORRESP 24, 3 21, EFFECT 19, 10-Q 18, UPLOAD 18, 424B3 14, S-1 9, S-1/A 8, 425 7, 10-K 6, DEF 14A 6, DEFA14A 6, S-8 6, 4/A 5, D 5, POS AM 5, SC 13G 5, SCHEDULE 13G 5, S-3 4, SC 13G/A 4, 10-K/A 3, 424B5 3, 8-K/A 3, SCHEDULE 13G/A 3, DRSLTR 2, PRE 14A 2, S-4/A 2, S-8 POS 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, NT 10-K 1, NT 10-Q 1, S-3/A 1, S-4 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 17:11 ET | [8-K](/filings/0001213900-26-101492.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-101492 |
| 2026-09-09 | 16:31 ET | [10-K](/filings/0001213900-26-098419.md) | Annual report, period 2026-06-30 | 0001213900-26-098419 |
| 2026-07-22 | 16:28 ET | [8-K](/filings/0001213900-26-080414.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-080414 |
| 2026-07-10 | 16:02 ET | [8-K](/filings/0001213900-26-077127.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-077127 |
| 2026-06-10 | 21:32 ET | [SCHEDULE 13D](/filings/0001213900-26-067514.md) | Ownership report, active investor | 0001213900-26-067514 |
| 2026-06-10 | 06:01 ET | [8-K](/filings/0001062993-26-003132.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-003132 |
| 2026-05-19 | 10:32 ET | [8-K](/filings/0001213900-26-058795.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058795 |
| 2026-05-19 | 06:03 ET | [8-K](/filings/0001062993-26-002787.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-002787 |
| 2026-05-07 | 18:12 ET | [8-K](/filings/0001062993-26-002371.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-002371 |
| 2026-05-06 | 17:25 ET | [10-Q](/filings/0001213900-26-052920.md) | Quarterly report, period 2026-03-31 | 0001213900-26-052920 |
| 2026-04-27 | 16:58 ET | [8-K](/filings/0001213900-26-048064.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-048064 |
| 2026-04-03 | 16:19 ET | [8-K](/filings/0001213900-26-039943.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-039943 |
| 2026-03-30 | 17:37 ET | [8-K](/filings/0001062993-26-001697.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001062993-26-001697 |
| 2026-03-23 | 07:31 ET | [8-K](/filings/0001062993-26-001567.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-001567 |
| 2026-03-09 | 07:43 ET | [8-K](/filings/0001062993-26-001347.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-001347 |
| 2026-03-06 | 16:58 ET | [8-K](/filings/0001213900-26-024752.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-024752 |
| 2026-02-12 | 20:51 ET | [8-K](/filings/0001062993-26-000819.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-000819 |
| 2026-02-11 | 17:04 ET | [10-Q](/filings/0001213900-26-014996.md) | Quarterly report, period 2025-12-31 | 0001213900-26-014996 |
| 2025-12-18 | 11:55 ET | [8-K](/filings/0001062993-25-017390.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-25-017390 |
| 2025-12-15 | 09:32 ET | [8-K](/filings/0001213900-25-121497.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-121497 |
| 2025-11-19 | 16:28 ET | [8-K](/filings/0001213900-25-112644.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-112644 |
| 2025-11-06 | 16:06 ET | [10-Q](/filings/0001213900-25-107152.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107152 |
| 2025-11-03 | 08:00 ET | [DEF 14A](/filings/0001213900-25-104914.md) | Proxy statement, period 2025-12-17 | 0001213900-25-104914 |
| 2025-10-24 | 16:05 ET | [10-K/A](/filings/0001213900-25-102157.md) | Annual report, amended, period 2025-06-30 | 0001213900-25-102157 |
| 2025-10-16 | 16:01 ET | [8-K](/filings/0001213900-25-099529.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-099529 |
| 2025-10-14 | 19:50 ET | [8-K](/filings/0001213900-25-098229.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-098229 |
| 2025-10-14 | 17:40 ET | [8-K](/filings/0001213900-25-098205.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-098205 |
| 2025-09-23 | 17:24 ET | [8-K](/filings/0001213900-25-090715.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-090715 |
| 2025-09-23 | 17:11 ET | [8-K](/filings/0001213900-25-090695.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-090695 |
| 2025-09-23 | 17:46 ET | [10-K](/filings/0001213900-25-090210.md) | Annual report, period 2025-06-30 | 0001213900-25-090210 |
| 2025-09-08 | 19:25 ET | [8-K](/filings/0001213900-25-085213.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-085213 |
| 2025-08-01 | 17:55 ET | [S-1/A](/filings/0001213900-25-070112.md) | Registration statement, amended | 0001213900-25-070112 |
| 2025-07-28 | 15:58 ET | [8-K](/filings/0001213900-25-068190.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-068190 |
| 2025-07-09 | 17:27 ET | [S-1](/filings/0001213900-25-062428.md) | Registration statement | 0001213900-25-062428 |
| 2025-06-30 | 16:16 ET | [8-K](/filings/0001213900-25-059673.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059673 |
| 2025-06-24 | 14:35 ET | [8-K](/filings/0001213900-25-057139.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-057139 |
| 2025-06-13 | 16:30 ET | [8-K](/filings/0001213900-25-054315.md) | 1.01 Entry into a material agreement; 4.01 Change of auditor; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-054315 |
| 2025-05-16 | 17:15 ET | [DEF 14A](/filings/0001213900-25-044948.md) | Proxy statement, period 2025-06-13 | 0001213900-25-044948 |
| 2025-05-13 | 06:19 ET | [8-K](/filings/0001213900-25-042251.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042251 |
| 2025-05-12 | 17:27 ET | [10-Q](/filings/0001213900-25-042126.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042126 |
| 2025-04-25 | 17:05 ET | [8-K](/filings/0001213900-25-035646.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-035646 |
| 2025-04-08 | 17:40 ET | [8-K](/filings/0001213900-25-029501.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-029501 |
| 2025-02-14 | 14:56 ET | [8-K](/filings/0001213900-25-014154.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-014154 |
| 2025-02-13 | 09:38 ET | [8-K](/filings/0001213900-25-013204.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-013204 |
| 2025-02-12 | 17:30 ET | [10-Q](/filings/0001213900-25-013063.md) | Quarterly report, period 2024-12-31 | 0001213900-25-013063 |
| 2025-02-03 | 11:20 ET | [8-K](/filings/0001213900-25-009213.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-009213 |
| 2025-01-22 | 10:18 ET | [8-K](/filings/0001213900-25-005263.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-005263 |
| 2025-01-21 | 10:54 ET | [8-K](/filings/0001213900-25-004873.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-004873 |
| 2024-12-30 | 12:16 ET | [S-1/A](/filings/0001213900-24-113340.md) | Registration statement, amended | 0001213900-24-113340 |
| 2024-12-23 | 17:16 ET | [S-1](/filings/0001213900-24-111992.md) | Registration statement | 0001213900-24-111992 |

Page 1 of 5. [Older](/companies/inm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.